CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

Antidepressants Administered using Weight-Based Dosing Strategies for Depression: Clinical Effectiveness and Guidelines

Last updated: December 14, 2020
Project Number: RB1533-000
Product Line: Rapid Response
Research Type: Drug
Report Type: Summary of Abstracts
Result type: Report

Question

  1. What is the clinical effectiveness of selective serotonin reuptake inhibitors and other antidepressants administered using weight-based dosing strategies for the treatment of individuals with depression?
  2. What are the evidence-based guidelines regarding the use of weight-based dosing strategies for selective serotonin reuptake inhibitors and other antidepressants for the treatment of individuals with depression?

Key Message

No evidence was identified regarding the clinical effectiveness of selective serotonin reuptake inhibitors and other antidepressants administered using weight-based dosing strategies for the treatment of individuals with depression. One evidence-based guideline was identified regarding the use of weight-based dosing strategies for selective serotonin reuptake inhibitors and other antidepressants for the treatment of individuals with depression.